Positron emission tomography in lung cancer

被引：11
|
作者：
Nomori H. [1 ,2 ]
Ohba Y. [1 ]
Yoshimoto K. [1 ]
Shibata H. [1 ]
Shiraishi K. [1 ]
Mori T. [1 ]
机构：
[1] Department of Thoracic Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556
[2] Department of Surgery, School of Medicine, Keio University, Shinjuku-ku, Tokyo 160-8582
来源：
General Thoracic and Cardiovascular Surgery | 2009年 / 57卷 / 4期
关键词：
Chemoradiotherapy; Lung cancer; Positron emission tomography; Prognosis; Staging;
D O I：
10.1007/s11748-008-0371-3
中图分类号：
学科分类号：
摘要：
Recent advances in positron emission tomography (PET) with 2-deoxy-2-fluoro [F-18]-d-glucose (FDG) has enabled not only the diagnosis and staging of lung cancer but also the prediction of its malignancy grade. However, FDG-PET has been known to have several pitfalls for imaging of lung cancer. For the effective clinical use of FDG-PET in lung cancer, we reviewed the pitfalls of using FDG-PET in the diagnosis of pulmonary nodules, semiquantitative analysis of FDG-uptake, N-staging, prediction of tumor aggressiveness, prognostic significance, and prediction of pathological response after chemoradiotherapy. © 2009 The Japanese Association for Thoracic Surgery.
引用
收藏
页码：184 / 191
页数：7
相关论文
共 50 条
  • [41] Positron Emission Tomography in Staging Early Lung Cancer A Randomized Trial
    Maziak, Donna E.
    Darling, Gail E.
    Inculet, Richard I.
    Gulenchyn, Karen Y.
    Driedger, Albert A.
    Ung, Yee C.
    Miller, John D.
    Gu, Chu-Shu
    Cline, Kathryn J.
    Evans, William K.
    Levine, Mark N.
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (04) : 221 - W48
  • [42] Lung cancer subtype differentiation from positron emission tomography images
    Ayyildiz, Oguzhan
    Aydin, Zafer
    Yilmaz, Bulent
    Karacavus, Seyhan
    Senkaya, Kubra
    Icer, Semra
    Tasdemir, Arzu
    Kaya, Eser
    TURKISH JOURNAL OF ELECTRICAL ENGINEERING AND COMPUTER SCIENCES, 2020, 28 (01) : 262 - 274
  • [43] Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer
    Sazon, DAD
    Santiago, SM
    Hoo, GWS
    Khonsary, A
    Brown, C
    Mandelkern, M
    Blahd, W
    Williams, AJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (01) : 417 - 421
  • [44] Positron emission tomography imaging in nonsmall-cell lung cancer
    Erasmus, Jeremy J.
    Macapinlac, Homer A.
    Swisher, Stephen G.
    CANCER, 2007, 110 (10) : 2155 - 2168
  • [45] Detection of extrathoracic metastases by positron emission tomography in lung cancer - Discussion
    Sundaresan, SR
    Pairolero, PC
    Varela, A
    Chapman, ND
    Lowe, VJ
    Anderson, RP
    Coleman, EJ
    Weder
    ANNALS OF THORACIC SURGERY, 1998, 66 (03): : 892 - 893
  • [46] The role of positron emission tomography in management of small cell lung cancer
    Thomson, D.
    Hulse, P.
    Lorigan, P.
    Faivre-Finn, C.
    LUNG CANCER, 2011, 73 (02) : 121 - 126
  • [47] Suspicious Positron Emission Tomography (pet) Positive Lung Nodule - Is It Cancer?
    Albano, D.
    Bilfinger, T.
    Nemesure, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [48] Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer
    Berberoglu, Kezban
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2016, 25 (02) : 50 - 62
  • [49] AN AUDIT TO ASSESS THE ACCURACY OF POSITRON EMISSION TOMOGRAPHY SCANNING IN LUNG CANCER
    Rich, A. L.
    Nandi, N.
    Cox, G. M.
    Amsha, K. A.
    Baldwin, D. R.
    Lim, W. S.
    THORAX, 2008, 63 : A69 - A70
  • [50] Indications for positron emission tomography and bone gammagraphy in staging lung cancer
    Cabrera-Rodriguez, Joaquin
    Garcia-Bernardo, Lucia
    Quiros-Rivero, Juan
    ARCHIVOS DE BRONCONEUMOLOGIA, 2012, 48 (08): : 300 - 300
12345